Before 2007 when we started using TA-65 with psoriasis patients, we might have thought that was an immune enhancer might have been concerning for autoimmune-type diseases.
In the case of psoriasis and other conditions, immune-enhancing adaptogens don’t appear to worsen and may be associated with a benefit.
DISCLAIMER: This website is for educational purposes only and is not for advertising. Telomerase activators and nanovesicles are not FDA-approved to prevent or treat any disease and anecdotes are not scientific proof of efficacy. All patients were treated in the context of a fully informed and legally-protected patient physician relationship.
Required fields
© 2020 Recharge Biomedical
Exosomes and TA-65 are not FDA-approved to prevent or treat any illness
